PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Human Drug Repurposing and Medicines Research, University of Newcastle, NSW, 2305, Australia.\', \'University of South Australia, South Australia, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/bcp.14551
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32959913
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32959913>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32959913>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all